Brief Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2011; 17(17): 2241-2247
Published online May 7, 2011. doi: 10.3748/wjg.v17.i17.2241
Table 1 Serum levels of amylase and PLA2, quantity of ascites and pathological scores (n = 10) (mean ± SD)
GroupAmylase (U/L)PLA2 (μmol/min per mililiter)Ascites (mL)Pathological scores
SO1923 ± 527ac0.0434 ± 0.019ac0.0ac0ac
SAP6448 ± 240c 0.2990 ± 0.0225c5.4 ± 1.3c9.15 ± 0.55c
DMSO6070 ± 464c 0.2728 ± 0.4461c5.0 ± 2.0c9.10 ± 0.65c
BN14744 ± 1031ac0.2320 ± 0.0890ac2.4 ± 0.9a6.65 ± 0.42a
BN2 3452 ± 548a 0.1049 ± 0.0528a1.6 ± 0.5a5.55 ± 0.36a
BN34777 ± 168ac 0.1069 ± 0.0440a2.6 ± 0.9a5.90 ± 0.19a
SS4646 ± 675ac0.1632 ± 0.0523ac2.4 ± 0.5a5.70 ± 0.30a
Table 2 Expression of platelet activating factor receptor in pancreatic tissues (n = 10) (mean ± SD)
GroupRatio of PAFR/β-actin mRNAIOD of PAFR
SO0.46 ± 0.10a5394.6 ± 1739.4a
SAP0.38 ± 0.08c1881.2 ± 376.7c
DMSO0.39 ± 0.09c2105.4 ± 345.2c
BN10.54 ± 0.14a19966.7 ± 6488.7a
BN20.60 ± 0.09a20935.6 ± 6551.9a
BN30.60 ± 0.09a2169.7 ± 6872.5a
SS0.59 ± 0.08a20897.5 ± 666.2a